en · de · es · fr · pt
epitalon-notes.peptides9000.com › News › Epitalon Background And Identification — Worked Examples

Epitalon Background And Identification — Worked Examples

By Editorial Desk · published 2025-10-07 · last reviewed 2025-11-06 · News

AEDG raises a handful of sensible questions. This page answers them in order, starting with the fundamentals and moving to applications.

Reviewed 2025-11-06. Anything still debated is marked as such rather than presented as settled.

Epitalon Background And Identification

Epitalon is a synthetic tetrapeptide with the residue sequence alanine-glutamate-aspartate-glycine, commonly abbreviated AEDG. Its monoisotopic mass is approximately 390.35 daltons, and it is usually supplied as a lyophilised trifluoroacetate or acetate salt. The compound was derived from a pineal gland extract called epithalamin, a heterogeneous preparation investigated in the former Soviet Union. Researchers associated with the Saint Petersburg Institute of Bioregulation and Gerontology described the tetrapeptide as a constituent fragment of that extract. Commercial material is offered as a laboratory reagent rather than as a finished pharmaceutical product.

Literature searches for this compound must account for several spelling variants. Indexing databases contain epitalon, epithalon, epithalone, and AEDG, and relevant records are scattered across Russian-language and English-language journals that do not consistently cross-cite. Early publications describe the parent extract as a mixture of many peptides, whereas later work addresses the single synthetic tetrapeptide. That shift in nomenclature complicates comparison between studies, because extract data and tetrapeptide data are sometimes cited interchangeably. A search strategy omitting the alternate spellings will return an incomplete set of references.

Identity and Research Background

The peptide is a synthetic analogue of epithalamin, a preparation extracted from bovine pineal glands. Investigators sought a short, chemically defined molecule that would reproduce some of the endocrine and gerontological observations attributed to the glandular extract. Proposed mechanisms centre on induction of telomerase activity, an effect reported in cultured human somatic cells in the early 2000s, together with influences on melatonin secretion and neuroendocrine regulation. Those mechanisms remain incompletely characterised, and the reported telomerase response has not been consistently reproduced by independent groups working in comparable systems.

Published work on this compound consists mainly of in vitro experiments, animal studies, and small clinical investigations, a substantial share of which appeared in Russian-language journals. Sample sizes are generally small, control conditions differ between studies, and several endpoints rely on markers whose clinical meaning is itself debated. Reviews of the longevity field treat the peptide as an early example of telomerase-directed research rather than an established intervention. Regulatory treatment varies by country: some jurisdictions place it under prescription controls, others treat it as a laboratory material, and importation may be restricted regardless of local status.

Epitalon at a glance

PropertyValueNotes
Chemical classSynthetic tetrapeptideFour amino acid residues
Residue sequenceAla-Glu-Asp-GlyAbbreviated AEDG
Approximate mass390.35 DaMonoisotopic, free base form
Parent preparationEpithalamin extractDerived from pineal tissue
Common spelling variantsEpithalon, epithalone, AEDGAffects literature retrieval

Peptide Identity and Laboratory Handling

Storage recommendations center on limiting moisture, heat, and light. The dry powder is generally kept at minus 20 degrees Celsius, and some suppliers recommend minus 80 degrees for long-term archival. Once dissolved, solutions are usually aliquoted and frozen to avoid repeated freeze-thaw cycles, which can promote aggregation or degradation. Aqueous stability depends on pH and concentration, and buffered saline is often preferred over plain water for biological work. Stability data specific to epitalon remain limited, so general peptide-handling practices are applied by analogy rather than from product-specific validation.

Epitalon is a synthetic tetrapeptide with the sequence alanine-glutamate-aspartate-glycine, abbreviated AEDG. Its molecular formula is C14H22N4O9 and its calculated monoisotopic mass is approximately 390.35 daltons. The compound does not occur naturally as a free peptide; it is produced by solid-phase peptide synthesis. Because it contains two acidic residues and no basic residues, the neutral form carries a net negative charge at physiological pH. This charge profile influences how the peptide behaves in solution and during chromatographic analysis.

Related pages on this site

Background and Proposed Mechanism

Published evidence comes mainly from Russian-language journals and from a single research group, with small sample sizes and limited independent replication. A few laboratories outside that group have examined related peptides and reported weaker or absent telomerase effects, so the central claim is best described as contested rather than settled. Rodent studies report modest changes in some ageing markers and in survival, but designs vary and control conditions are often sparse. No large randomised trial in humans has been published, and long-term safety data in healthy populations are correspondingly thin.

Epitalon is a synthetic tetrapeptide with the sequence alanine-glutamate-aspartate-glycine, commonly abbreviated AEDG. It was designed at the St. Petersburg Institute of Bioregulation and Gerontology as a short, chemically defined analogue of epithalamin, a fraction obtained from bovine pineal tissue. Small peptide bioregulators of this type formed a long-running line of work there from the 1980s onward. Because the molecule is produced by solid-phase synthesis rather than extraction, its composition is exact and its purity can be measured directly.

Background and Chemical Identity

Material supplied for laboratory use is normally a lyophilised white to off-white powder that dissolves readily in water and in isotonic saline. Lyophilised cakes are hygroscopic and should be equilibrated to room temperature before opening to limit condensation on the solid. Solutions are typically prepared at milligram-per-millilitre concentrations and divided into single-use aliquots, because repeated freeze–thaw cycles degrade short peptides. Aqueous solutions are far less stable than the dry powder, and identity is usually verified by mass spectrometry alongside purity estimation from reversed-phase high-performance liquid chromatography.

Epitalon is a synthetic linear tetrapeptide with the sequence alanine–glutamate–aspartate–glycine, abbreviated AEDG. Its molecular formula is C14H22N4O9 and the calculated mass is approximately 390.35 g/mol. The compound is made by solid-phase peptide synthesis rather than extracted from tissue, although early work described it as a short fragment of a peptide fraction obtained from bovine pineal extract. In the research literature the spelling epitalon and the variant epithalone both appear, while AEDG is the standard code used in peptide nomenclature.

Several names circulate for the same molecule, including epitalon, epithalone, epithalamin tetrapeptide, and the sequence code AEDG. A CAS registry number, 307297-39-8, is commonly cited for it, though catalogue entries should be checked against supplier documentation because mislabelled records occur. In its usual form the peptide carries free amino and carboxyl termini and is neither glycosylated nor lipidated. Researchers distinguish the defined tetrapeptide from epithalamin itself, a crude pineal preparation containing many peptides that is not chemically characterised.

Epitalon Peptide Background and Structure

The proposed relationship between epitalon and pineal function is a central part of its background. Khavinson's group reported that short peptides corresponding to regions of larger pineal proteins could influence gene expression in cells. Epitalon was framed as a synthetic analogue of an active fragment rather than a direct isolation product. Whether the tetrapeptide reproduces the effects of the parent extract is an open question, because comparative studies are limited and the parent extract itself is not a single defined substance.

Interest in epitalon is usually discussed within the broader field of short peptide bioregulators, a category that includes other synthetic di-, tri-, and tetrapeptides studied by the same research group. These compounds share a common rationale: that small fragments of tissue-derived proteins can retain biological activity and can be produced reproducibly. The category as a whole remains outside mainstream pharmacological consensus, and epitalon specifically has a limited presence in independent, non-Russian research literature, which shapes how its evidence base is described.

Epitalon is a synthetic tetrapeptide with the amino acid sequence alanine-glutamate-aspartate-glycine, abbreviated Ala-Glu-Asp-Gly or AEDG. It was developed by the Russian researcher Vladimir Khavinson and colleagues during work on peptide bioregulators derived from the pineal gland. The compound is short enough to be produced by standard solid-phase peptide synthesis and is typically handled as a lyophilized white powder. Its small size distinguishes it from larger pineal peptides such as epithalamin, a complex extract from which the tetrapeptide was conceptually derived.

Notes from published material

Subject to its constitutional principles and the basic concepts of its legal system, each Party shall adopt such measures as may be necessary to establish as a criminal offence under its domestic law, when committed intentionally, the possession, purchase or cultivation of narcotic drugs or psychotropic substances for personal consumption contrary to the provisions of the 1961 Convention, the 1961 Convention as amended or the 1971 Convention. Previous drug control treaties had targeted drug manufacturers and traffickers, rather than users. In their 2003 article, "The Mechanics and Dynamics of the UN System for International Drug Control," David Bewley-Taylor and Cindy Fazey explain that "[t]he 1988 Convention was an attempt to reach a political balance between consumer and producer countries. Consequently, it was not only the duty of producing countries (e.g. the developing countries of Asia and South America) to suppress illicit supply, but also the duty of consumer countries (e.g.

Injection of corticosteroids may or may not alleviate symptoms better than simulated (placebo) injections. There is no evidence that corticosteroid injection sustainably alters the natural history of the disease, which seems to be a gradual progression of neuropathy. Surgery to cut the transverse carpal ligament is the only known disease modifying treatment.

An alternative approach used to measure the relative abundance of radiogenic isotopes when working with a solid surface is secondary-ion mass spectrometry (SIMS). This type of ion-microprobe analysis normally works by focusing a primary (oxygen) ion beam on a sample in order to generate a series of secondary positive ions that can be focused and measured based on their mass/charge ratios. SIMS is a common method used in U-Pb analysis, as the primary ion beam is used to bombard the surface of a single zircon grain in order to yield a secondary beam of Pb ions. The Pb ions are analyzed using a double focusing mass spectrometer that comprises both an electrostatic and magnetic analyzer. This assembly allows the secondary ions to be focused based on their kinetic energy and mass-charge ratio in order to be accurately collected using a series of Faraday cups. A major issue that arises in SIMS analysis is the generation of isobaric interference between sputtered molecular ions and the ions of interest. This issue occurs with U–Pb dating as Pb ions have essentially the same mass as HfO2+. In order to overcome this problem, a sensitive high-resolution ion microprobe (SHRIMP) can be used. A SHRIMP is a double-focusing mass spectrometer that allows for a large spatial separation between different ion masses based on its relatively large size. For U-Pb analysis, the SHRIMP allows for the separation of Pb from other interfering molecular ions, such as HfO2+.

== History == Flagler Global Logistics can trace its roots back to the original railroad and land development company founded by pioneering American businessman Henry M. Flagler in 1892. Flagler, who helped found Standard Oil, saw Florida's tourism potential and built a network of rail lines, depots, and associated infrastructure that eventually extended all the way from Jacksonville to Key West. As Florida's east coast was still lightly settled, Flagler was able to obtain wide swaths of land up and down the coast, including large tracts of property in what became Miami. After a long bankruptcy that began in 1931, Florida East Coast Railway was purchased by the Alfred I. duPont Testamentary Trust and operated as part of the St. Joe Company. In 1983, St. Joe's incorporated FOXX Holdings, which became the parent company of both Florida East Coast Railway and the railroad's new real estate arm, Flagler Development Company. FOXX was renamed Florida East Coast Industries in April 2000. In 2007, Florida East Coast Industries was purchased by Fortress Investment for $3.5 billion, and shortly afterwards, Florida East Coast Railway was spun off into a separate and distinct company from Florida East Coast Industries. To better take advantage of its strategic land holdings, and provide scalable third-party logistics, Florida East Coast Industries established South Florida Logistics Services as an LLC in Delaware in April 2013. The company officially incorporated in the state of Florida in May 2013.

Sources: en.wikipedia.org

Further detail

== Wavelength and energy ranges == The electromagnetic spectrum of ultraviolet radiation (UVR), defined most broadly as 100–400 nanometers, can be subdivided into a number of ranges recommended by the ISO standard ISO 21348:

An adrenaline junkie is someone who "has a compulsive desire for extreme excitement". Such activities include extreme and risky sports, substance abuse, unsafe sex, and crime. The term relates to the increase in circulating levels of adrenaline during physiological stress. Such an increase in the circulating concentration of adrenaline is secondary to the activation of the sympathetic nerves innervating the adrenal medulla, as it is rapid and not present in animals where the adrenal gland has been removed. Although such stress triggers adrenaline release, it also activates many other responses within the central nervous system reward system, which drives behavioral responses; while the circulating adrenaline concentration is present, it may not drive behavior. Nevertheless, adrenaline infusion alone does increase alertness and has roles in the brain, including the augmentation of memory consolidation.

Class IA Class IA antiarrhythmic drugs work by blocking sodium and potassium channels. Blocking sodium channels tend to shorten the action potential duration, while blocking potassium channels prolongs the action potential. When the drug concentration is at a low to normal concentration, the potassium channel blocking activity takes precedence over the sodium channel blocking activity Disopyramide Procainamide Propafenone Quinidine Because of the predominance of the potassium blocking activity, TdP is seen more frequently with therapeutic levels of quinidine. Sodium blocking activity is dominant with subtherapeutic levels, which does not lead to QT prolongation and TdP. Class III Class III antiarrhythmic drugs are potassium channel blockers that cause QT prolongation and are associated with TdP. Amiodarone Amiodarone works in many ways. It blocks sodium, potassium, and calcium channels, as well as alpha and beta adrenergic receptors. Because of its multiple actions, amiodarone causes QT prolongation but TdP is rarely observed. Dofetilide Ibutilide Ibutilide differs from other class III antiarrhythmic agents in that it activates the slow, delayed inward sodium channels rather than inhibiting outward potassium channels. Sotalol Sotalol has beta-blocking activity. Approximately 2 to 7 percent of patients taking at least 320 mg/day experience proarrhythmia, most often in the form of TdP. The risks and effects are dose-dependent.

=== False eggs === Calculus: Calculi are egg-like objects formed in the stomachs of ruminants such as cattle, deer, elk, and goats. Calculus formation is a defense mechanism protecting the ruminant's stomach from damage if it swallows a foreign object while grazing. After ingestion, the object is covered by the same material composing bone, calcium phosphate, and eventually vomited out of the animal's system. These "stomach stones" tend to range in size from 1 to 6 centimeters. Larger sizes are known but very rare. Sometimes tiny dimples cover the surface of a stomach stone, which can fool observers into thinking they are the pores of an egg. Fossil egg expert Ken Carpenter has described stomach stones as the most egg-like natural objects, noting that they are "the trickiest [egg-like] objects to correctly identify". Calculi are so egg-like that on one occasion a detailed description of a stomach stone misidentified as a fossil egg was published in the scientific literature. Calculi can be distinguished from real egg fossils because when they are broken open, they show the layers of calcium phosphate and the foreign object at the core. Multiple layers of eggshell are known in pathological eggs, but these layers don't go all the way down to its core the way a stomach stone's do. Calculi are often suspiciously intact, unlike fossil eggs, which are usually damaged. Stomach stones also lack distinct shells with their attending structural components like continuous or prismatic layers, mammillae, and pores.

This makes it a highly effective treatment for negative and cognitive symptoms of schizophrenia since 5HT2A antagonism increases dopamine release in the mesocortical pathway which is hypoactive in those with schizophrenia. Interestingly, lumateperone indirectly augments glutamatergic neurotransmission through its activity at D1 receptors, which causes phosphorylation of GluN2B subunits of NMDA receptors in the mesolimbic pathway. This is significant since NMDA receptor hypofunction, reduced D1 binding, and glutamatergic abnormalities have been implicated in contributing to the cognitive and negative symptoms of schizophrenia. It has also been identified as a potent vesicular monoamine transporter 2 (VMAT2) inhibitor (IC50Tooltip half-maximal inhibitory concentration = 62 nM).

Sources: en.wikipedia.org

Frequently asked questions

What is epitalon derived from?

It is based on epithalamin, a peptide-rich preparation obtained from pineal gland tissue and studied in the former Soviet Union. Researchers later identified the tetrapeptide AEDG as a constituent fragment of that material. Modern supplies are produced by chemical synthesis rather than tissue extraction.

Is epitalon identical to epithalamin?

No. Epithalamin is a heterogeneous extract containing many peptides, while epitalon is a single synthesised tetrapeptide. Publications sometimes treat findings from the two as equivalent, which is a common source of confusion. Their compositions differ and they are not interchangeable in analytical terms.

Why are human studies so limited?

Most published work uses cell cultures or rodents because those models are faster and less costly to run. The few human trials that have been reported are small, and several lack control groups or blinding. This restricts what can reasonably be concluded about effects in people.

What is epitalon?

Epitalon is a synthetic four-amino-acid peptide with the sequence alanine–glutamate–aspartate–glycine, also written AEDG. It was developed in Russian gerontology research and is studied for proposed effects on telomerase, melatonin regulation, and neuroendocrine function. It is not an approved pharmaceutical in the United States or the European Union.

Network